Abiopharma

MASSARANY HANY 🟢 acquired 13.8K shares (2 derivative) of BIODESIX INC (BDSX) at $6.46 Transaction Date: Jan 02, 2026 | Filing ID: 000071

Kennedy Lawrence T. Jr 🟢 acquired 11.8K shares (2 derivative) of BIODESIX INC (BDSX) at $6.46 Transaction Date: Jan 02, 2026 | Filing ID: 000070

Kayyem Jon Faiz 🟢 acquired 11.8K shares (2 derivative) of BIODESIX INC (BDSX) at $6.46 Transaction Date: Jan 02, 2026 | Filing ID: 000069

📋 Boulding Mark Elliott (Officer) plans to sell 2K shares of PTC THERAPEUTICS, INC. (at $76.95 each, total $134K) Filed: Jan 06, 2026 | ID: 000157

Pestano Gary Anthony 🟢 acquired 26.0K shares (1 derivative) of BIODESIX INC (BDSX) at $6.46 Transaction Date: Jan 02, 2026 | Filing ID: 000068

O'Kane Kieran 🟢 acquired 27.0K shares (1 derivative) of BIODESIX INC (BDSX) at $6.46 Transaction Date: Jan 02, 2026 | Filing ID: 000067

📋 Gravier Pierre (Officer) plans to sell 2K shares of PTC THERAPEUTICS, INC. (at $76.95 each, total $165K) Filed: Jan 06, 2026 | ID: 000156

Hutton Scott 🟢 acquired 97.0K shares (1 derivative) of BIODESIX INC (BDSX) at $6.46 Transaction Date: Jan 02, 2026 | Filing ID: 000066

Cowie Robin Harper 🟢 acquired 29.0K shares (1 derivative) of BIODESIX INC (BDSX) at $6.46 Transaction Date: Jan 02, 2026 | Filing ID: 000065

📋 Badawi David (Officer) plans to sell 4K shares of Sight Sciences, Inc. (at $7.48 each, total $28K) Filed: Jan 06, 2026 | ID: 000155

Vazquez Chris 🟢 acquired 12.0K shares (1 derivative) of BIODESIX INC (BDSX) at $6.46 Transaction Date: Jan 02, 2026 | Filing ID: 000064

(99% Neutral) PRAXIS PRECISION MEDICINES, INC. (PRAX) Reports Q1 2026 Financial Results

📋 Rodberg James (Officer) plans to sell 594 shares of Sight Sciences, Inc. (at $7.48 each, total $4K) Filed: Jan 06, 2026 | ID: 000154

📋 Almstead Zheng Yang (Member of immediate family of any of the foregoing) plans to sell 54 shares of PTC THERAPEUTICS, INC. (at $76.95 each, total $4K) Filed: Jan 06, 2026 | ID: 000153

Martin Samuel Bates 🟡 adjusted position in 0 shares (1 derivative) of Celldex Therapeutics, Inc. (CLDX) at $10.38 Transaction Date: Jan 02, 2026 | Filing ID: 000002